Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes. FE [Internet]. 2020 Dec. 23 [cited 2025 Oct. 29];21(1S). Available from: https://journals.seedstm.com/index.php/FE/article/view/1490